Danaflex-Lab ApS: Financial statements 2025
CVR: 43725157
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Danaflex-Lab ApS (CVR 43725157) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 492,957 and a net result of DKK 206,339 compared with DKK 247,320 the year before. That is an increase of 52.8% compared with the year before. Equity in the 2025 report amounted to DKK 406,337. The solvency ratio was 53.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 492,957
- Profit/Loss
- DKK 206,339
- Equity
- DKK 406,337
- Total Assets
- DKK 759,708
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 493K | 206K | 406K | 1 |
| 2024 | - | 323K | 247K | 200K | 1 |
| 2023 | - | -104K | -87K | -47K | 1 |
Official annual report
How creditworthy is Danaflex-Lab ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Danaflex-Lab ApS has published its annual report for 2024. Gross profit came to DKK 322,661, and the net result was DKK 247,320.
About Danaflex-Lab ApS
Danaflex-Lab ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2022. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Kristian Skov Alanin. The company is owned by ALANIN HOLDING ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 492,957 and a net result of DKK 206,339 compared with DKK 247,320 the year before. Equity in the 2025 report amounted to DKK 406,337.